Susan F. Wood
Areas of Expertise & Civic Involvements
Wood has committed much of her professional career to ensuring that health and science policy is based upon the best available evidence and research data. Her work and scholarship reflects this overarching theme and centers around identifying research gaps that address key health issues, thus providing useful information to policymakers. This has come together as a focus on women’s health research combined with the role of Federal Agencies, such as the FDA, in regulatory and research policies. Wood has contributed significantly to the national women’s health research and policy agenda over the last two decades, through work on issues related to emergency contraception and related reproductive health topics, inclusion of women in clinical research, and scientific integrity. She has collaborated widely with policymakers and advocates to promote women’s health and research.
Examines the role of community health centers in providing comprehensive family planning services to adolescents, looking at the range of services offered and factors associated with provision of these services.
Analyses utilization and behaviors of Latino adolescents as changes in social media trends occur, including sending/receiving short message service (SMS) and social networking. Examines the social media utilization among Latino youth, and differences by sex and acculturation.
Argues that the scientific and medical communities must defend the evidence of the health benefits to women and to families with access to family planning tools, including emergency contraception. Highlights the need to ensure that safe, effective, and beneficial drugs are made as available as possible.
Covers some of the pertinent history of the FDA regulation of medications and devices important to women’s health care. Discusses some of the challenges in progress, and advances some proposals for improved safety and efficacy of drugs in pregnant women.
Reports on the scope of services provided at Federally Qualified Health Centers (FQHCs) including on-site provision, prescription only and referral options for the range of contraceptive methods.
Argues that the 2012 scaling back of limits on FDA advisory panel financial conflicts had no clear basis and may have unanticipated impacts.